Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”) is a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry. Our products/services are based on three patented, pressure-based platforms: (i) Pressure Cycling Technology (“PCT”), (ii) Pressure Enabled Protein Manufacturing Technology (“PreEMT”), and (iii) Ultra Shear Technology (“UST”). We have over 300 instruments placed in approximately 200 sites worldwide, there are over 120 publications that speak to the advantages of our three unique platform technologies, and we reported sales of over $2.2 million in 2017.